137 related articles for article (PubMed ID: 6448845)
1. The binding of low molecular weight heparin to hemostatic enzymes.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10073-80. PubMed ID: 6448845
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
3. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
4. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
[TBL] [Abstract][Full Text] [Related]
5. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
6. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
7. Multiple functional domains of the heparin molecule.
Oosta GM; Gardner WT; Beeler DL; Rosenberg RD
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):829-33. PubMed ID: 6940150
[TBL] [Abstract][Full Text] [Related]
8. Fractionation of low molecular weight heparin species and their interaction with antithrombin.
Beeler D; Rosenberg R; Jordan R
J Biol Chem; 1979 Apr; 254(8):2902-13. PubMed ID: 429327
[TBL] [Abstract][Full Text] [Related]
9. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
Danielsson A; Raub E; Lindahl U; Björk I
J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
[TBL] [Abstract][Full Text] [Related]
10. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
11. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
Blaskó G
Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
[TBL] [Abstract][Full Text] [Related]
12. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
Teitel JM; Rosenberg RD
J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
[TBL] [Abstract][Full Text] [Related]
13. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
Holmer E; Kurachi K; Söderström G
Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
[TBL] [Abstract][Full Text] [Related]
14. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
16. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of human coagulation factor IX by plasmin.
Samis JA; Ramsey GD; Walker JB; Nesheim ME; Giles AR
Blood; 2000 Feb; 95(3):943-51. PubMed ID: 10648407
[TBL] [Abstract][Full Text] [Related]
18. The catalysis by heparin of the reaction between thrombin and antithrombin.
Evington JR; Feldman PA; Luscombe M; Holbrook JJ
Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
[TBL] [Abstract][Full Text] [Related]
19. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
Pieters J; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
